Related Experiment Video
Updated: Jun 29, 2026
11:38
GENPLAT: an Automated Platform for Biomass Enzyme Discovery and Cocktail Optimization
Published on: October 24, 2011
Plant-derived L-asparaginases: Comprehensive functional and biological characterization
Zofia Mazurek1, Anna Ściuk2, Izabela Pieróg3
1Center for the Development of Therapies for Civilization and Age-Related Diseases, Jagiellonian University Medical College, Krakow, Poland.
International Journal of Biological Macromolecules
|June 27, 2026
Summary
Plant-derived L-asparaginases were evaluated for anti-leukemia activity. The K-dependent enzyme PvAIII(K)-1 demonstrated selective antiproliferative and proapoptotic effects on leukemia cells, highlighting its therapeutic potential.
Area of Science:
- Biochemistry
- Enzymology
- Molecular Biology
Background:
- L-asparaginases are crucial in leukemia treatment by depleting L-asparagine.
- Plant-derived L-asparaginases offer potential alternatives with varying properties.
- Understanding structure-activity relationships is key for enzyme optimization.
Purpose of the Study:
- To systematically analyze plant-derived type III L-asparaginases for catalytic and biological activities.
- To compare K-dependent and K-independent variants from Arabidopsis thaliana and Phaseolus vulgaris.
- To identify key structural features influencing enzyme stability and efficacy.
Main Methods:
- Enzyme characterization (catalytic properties, thermal stability via NanoDSF).
- Antiproliferative and proapoptotic assays on human leukemia cell lines.
- Molecular docking and molecular dynamics simulations.
- Site-directed mutagenesis.
Main Results:
- PvAIII(K)-1 showed high selectivity for MOLT-4 leukemia cells with minimal impact on other cell lines and lymphocytes.
- PvAIII(K)-1 exhibited significant antiproliferative and proapoptotic effects (IC50 = 0.0056 mg/mL) despite millimolar K-values.
- K-independent enzymes (AtAIII, PvAIII) had higher thermal stability than K-dependent ones.
- Specific residues (Glu81, Arg311) were identified as critical for PvAIII(K)-1 thermal stability.
- AtAIII displayed reduced substrate specificity due to active site residue Tyr204.
Conclusions:
- PvAIII(K)-1 possesses a favorable biological profile for targeted leukemia therapy.
- Enzyme engineering can optimize plant-derived L-asparaginases for enhanced efficacy and stability.
- Structural insights guide the rational design of improved anti-leukemia enzymes.
Related Concept Videos
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...